1.
A 45 y/o male is admitted for unstable angina. He is treated with 3 coronary artery stents. His HIV ELISA is positive, CD4 count is 100, and viral load is 250K. If you were to prescribe a protease inhibitor, which would be most likely to be beneficial?
2.
Which HAART regimen would be optimal for the above patient?
3.
The patient’s wife is tested and found to be HIV positive. She is 8 months pregnant. Her CD4 count is 340 and viral load is 38K. Which HAART regimen below would be most appropriate?
4.
A 23 y/o man is diagnosed with HIV. He is taking a one-pill combination of dolutegravir, abacavir and lamivudine. He had CD4 of 230 at time of diagnosis and HIV viral load of 750,000. At 6 months of follow up, his viral load is suppressed and CD4 is 380. His misses 2 appointments out of 4 in the next year. His most recent CD4 is 320 but his viral load is 2800. You send a genotype.
5.
The patient in question 4 has the mutation pattern conferring reduced susceptibility to dolutegravir as well as bictegravir. Which of the following is true?
